Once versus thrice daily gentamicin in patients with serious infections

The Lancet

Volumn 341, Issue 8841, 1993, Pages 335-339

  Prins, J M ^a   Buller, H R ^a   Speelman, P ^a   Kuijper, E J ^a   Tange, R A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; GENTAMICIN;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; NETHERLANDS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL INFECTIONS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GENTAMICINS; HUMAN; KIDNEY; LABYRINTH; MALE; MIDDLE AGE; PROSPECTIVE STUDIES;

EID: 0027518301     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(93)90137-6     Document Type: Article

References (31)

1. Aminoglycoside toxicity: a review of clinical studies published between 1975 and 1982
2. Once-daily aminoglycoside therapy
3. Determinants of efficacy and toxicity of aminoglycosides
4. Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia
5. In vivo postantibiotic effect in a thigh infection in neutropenic mice
6. Postantibiotic effects
7. Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacin
8. Once-daily dosing decreases renal accumulation of gentamicin and netilmicin
9. Influence of dosage schedule on renal cortical accumulation of amikacin and tobramycin in man
10. Once-daily vs continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin
11. The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure
12. Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs
13. A study of potential vestibulotoxic effects of once daily versus thrice daily administration of tobramycin
14. Once-daily dosing regimen for aminoglycoside plus β-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone
15. Prospective randomized study of once-daily versus thrice-daily netilmicin regimens in patients with intraabdominal infections
16. A multicentric study of netilmicin once daily versus thrice daily in patients with appendicitis and other intra-abdominal infections
17. Netilmicin in the treatment of gram-negative bacteremia single daily versus multiple daily dosage
18. Pharmacokinetic and toxicological evaluation of a once-daily regimen versus conventional schedules of netilmicin and amikacin
19. Pharmacodynamic parameters and toxicity of netilmicin (6 milligrams/kilogram/day) given once daily or in three divided doses to cancer patients with urinary tract infection
20. A study of amikacin given once versus twice daily in serious infections
21. Efficacy and safety of amikacin in systemic infections when given as a single daily dose or in two divided doses
22. APACHE II: a severity of disease classification system
23. Prediction of creatinine clearance from serum creatinine
24. Gentamicin serum concentrations: pharmacokinetic predictions
25. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin
26. A table of exact confidence limits for differences and ratios of two proportions and their odds ratios
27. Screening for aminoglycoside auditory toxicity in the old
28. Aminoglycoside-induced hearing loss in humans
29. Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial
30. What is the cost of nephrotoxicity associated with aminoglycosides?